Literature DB >> 20188206

Celastrol can inhibit proteasome activity and upregulate the expression of heat shock protein genes, hsp30 and hsp70, in Xenopus laevis A6 cells.

Shantel E Walcott1, John J Heikkila.   

Abstract

In eukaryotes, the ubiquitin-proteasome system (UPS) is responsible for the degradation of most proteins. Proteasome inhibition, which has been associated with various diseases, can cause alterations in various intracellular processes including the expression of heat shock protein (hsp) genes. In this study, we show that celastrol, a quinone methide triterpene and anti-inflammatory agent, inhibited proteasome activity and enhanced HSP accumulation in Xenopus laevis A6 kidney epithelial cells. Treatment of cells with celastrol induced the accumulation of ubiquitinated protein and inhibited chymotrypsin-like activity. This was accompanied by a dose- and time-dependent accumulation of HSP30 and HSP70. Celastrol-induced HSP accumulation was mediated by HSF1-DNA binding activity since this response was inhibited by the HSF1 activation inhibitor, KNK437. Simultaneous exposure of cells with celastrol plus either mild heat shock or the proteasome inhibitor, MG132, produced an enhanced accumulation of HSP30 that was greater than the sum of the individual stressors alone. Immunocytochemical analysis revealed that celastrol-induced HSP30 accumulation occurred in the cytoplasm in a granular pattern supplemented with larger circular HSP30 staining structures. HSP30 was also noted in the nucleus with less staining in the nucleolus. In some cells, celastrol induced the collapse of the actin cytoskeleton and conversion to a rounder morphology. In conclusion, this study has shown that celastrol inhibited proteasome activity and induced HSF1-mediated expression of hsp genes in amphibian cells. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188206     DOI: 10.1016/j.cbpa.2010.02.015

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  15 in total

1.  Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones.

Authors:  Chunzhang Yang; Cody L Swallows; Chao Zhang; Jie Lu; Hongbin Xiao; Roscoe O Brady; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-18       Impact factor: 11.205

2.  Synthesis and proteasome inhibition of lithocholic acid derivatives.

Authors:  Zhao Dang; Andrew Lin; Phong Ho; Dominique Soroka; Kuo-Hsiung Lee; Li Huang; Chin-Ho Chen
Journal:  Bioorg Med Chem Lett       Date:  2011-02-17       Impact factor: 2.823

3.  The central role of heat shock factor 1 in synaptic fidelity and memory consolidation.

Authors:  Philip L Hooper; Heather D Durham; Zsolt Török; Paul L Hooper; Tim Crul; László Vígh
Journal:  Cell Stress Chaperones       Date:  2016-06-09       Impact factor: 3.667

4.  The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.

Authors:  D Jantas; A Roman; J Kuśmierczyk; E Lorenc-Koci; J Konieczny; T Lenda; W Lasoń
Journal:  Neurotox Res       Date:  2013-01-10       Impact factor: 3.911

5.  Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease.

Authors:  Jolanta Konieczny; Danuta Jantas; Tomasz Lenda; Helena Domin; Anna Czarnecka; Katarzyna Kuter; Maria Śmiałowska; Władysław Lasoń; Elżbieta Lorenc-Koci
Journal:  Neurotox Res       Date:  2014-05-20       Impact factor: 3.911

6.  Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.

Authors:  Xiaoxi Han; Shengkun Sun; Ming Zhao; Xiang Cheng; Guozhu Chen; Song Lin; Yifu Guan; Xiaodan Yu
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

7.  Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance.

Authors:  Saad Khan; Ashley W Rammeloo; John J Heikkila
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells.

Authors:  Bin Peng; Xue Zhang; Fanfan Cao; Ying Wang; Limin Xu; Lu Cao; Chunxin Yang; Maoquan Li; Georges Uzan; Denghai Zhang
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

9.  Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells.

Authors:  S Boridy; P U Le; K Petrecca; D Maysinger
Journal:  Cell Death Dis       Date:  2014-05-08       Impact factor: 8.469

Review 10.  The 26S proteasome is a multifaceted target for anti-cancer therapies.

Authors:  Tatyana A Grigoreva; Vyacheslav G Tribulovich; Alexander V Garabadzhiu; Gerry Melino; Nickolai A Barlev
Journal:  Oncotarget       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.